BLUEHALO LABS, LLC — Department of Defense SBIR Phase II: MEDICAL RESEARCH AND DEVELOPMENT CONTRACT PROPOSAL DHA SBIR PHASE II ENHANCEMENT&PHASE III

BLUEHALO LABS, LLC — SBIR Phase II award from Department of Defense.

Summary

BlueHalo Labs, LLC received a $1.55 million SBIR Phase II award from the Defense Health Agency to develop a kinetic system for medical simulation. The funding supports Phase II enhancements and Phase III matching funds for medical research and development.

Amount
$1,550,000
Agency
Department of Defense · Defense Health Agency
Program / Phase
SBIR · Phase II
NAICS
541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Place of performance
MD
Period
2020-08-31 → 2023-09-30

Technology domains

Human Performance & Medical Modeling & Simulation

Description

MEDICAL RESEARCH AND DEVELOPMENT CONTRACT PROPOSAL DHA SBIR PHASE II ENHANCEMENT&PHASE III (MATCHING FUNDS) TITLED KINETIC SYSTEM FOR MEDICAL SIMULATION.

View on USASpending.gov ↗